1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. BB Biotech AG
  6. News
  7. Summary
    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report
Delayed Swiss Exchange  -  11:30 2022-07-01 am EDT
57.10 CHF   +0.88%
05/24BB BIOTECH AG : Disruptive technologies are changing an entire industry
EQ
04/22BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/22BB Biotech Swings To Q1 Loss As Total Returns Plummet
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

BB Biotech Forecasts Switch to FY21 Loss in 'Difficult Year'

01/21/2022 | 01:31am EDT


© MT Newswires 2022
All news about BB BIOTECH AG
05/24BB BIOTECH AG : Disruptive technologies are changing an entire industry
EQ
04/22BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/22BB Biotech Swings To Q1 Loss As Total Returns Plummet
MT
04/22BB Biotech AG publishes its interim report
EQ
04/22BB BIOTECH AG : Increased investment level balanced by established core holdings
EQ
04/12GLOBAL MARKETS LIVE : Honda, Shopify, Meta, ASOS, Gilead Sciences...
04/12BB Biotech Launches New Share Repurchase Program
MT
04/12BB Biotech AG concludes its share buyback program and launches a new buyback program
EQ
04/12BB Biotech AG announces an Equity Buyback.
CI
04/12BB Biotech AG authorizes a Buyback Plan.
CI
More news
Analyst Recommendations on BB BIOTECH AG
More recommendations
Financials
Sales 2022 796 M 826 M 826 M
Net income 2022 497 M 516 M 516 M
Net Debt 2022 278 M 289 M 289 M
P/E ratio 2022 4,31x
Yield 2022 7,08%
Capitalization 3 148 M 3 270 M 3 270 M
EV / Sales 2022 4,31x
EV / Sales 2023 5,14x
Nbr of Employees 10
Free-Float 97,7%
Chart BB BIOTECH AG
Duration : Period :
BB Biotech AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 57,10 CHF
Average target price 75,13 CHF
Spread / Average Target 31,6%
EPS Revisions
Managers and Directors
Michael Hutter Head-Finance & Compliance
Erich Hunziker Chairman-Supervisory Board
Daniel Koller Head-Investment Management
Clive A. Meanwell Vice Chairman-Supervisory Board
Thomas von Planta Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BB BIOTECH AG-25.99%3 270
MODERNA, INC.-40.96%59 644
IQVIA HOLDINGS INC.-23.78%40 704
LONZA GROUP AG-31.83%40 011
SEAGEN INC.16.50%33 154
CELLTRION, INC.-9.60%19 031